The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Setting Goals for Future Growth

Setting Goals for Future Growth

December 12, 2011 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
David I. Daikh, MD, PhD

Perhaps the most personally rewarding aspect of working with the ACR Research and Education Foundation (REF) is seeing the success that can come from setting lofty goals. First and foremost, the REF is a goal-oriented organization. The staff and volunteers are not only committed to the goal of ensuring the future of rheumatology, but they aspire to reach high and to lead in this effort.

You Might Also Like
  • REF: Looking at Recent Achievements and FInding Inspiration for the Future
  • Without You, ACR REF Wouldn’t Be Here
  • ACR REF Launches ‘Within Our Reach’
Explore This Issue
December 2011
Also By This Author
  • Osteonecrosis

The success of the recently completed Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign is a prime example of the power of this approach, and of the effectiveness of this organization. When the ACR identified a critical need for basic and clinical research in RA that coincided with a glaring gap in funding for research in the field by the National Institutes of Health (NIH), the REF set a goal of addressing this need and embarked on a new and bold campaign to raise funds for disease-targeted research. The organization had never attempted a targeted campaign or any fundraising effort close to this size, and some questioned whether it would be possible. Yet, with deliberate and strategic planning, tireless work by a competent and professional development team, and committed volunteer leadership, the campaign surpassed its $30-million goal in its fifth year, as planned. Among the many accomplishments of this program, the research funded by the Within Our Reach campaign has already led to a remarkable $59 million in additional related research grants funded by the NIH.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

During the course of the campaign, the REF received a top four-star Charity Navigator designation in recognition of the organization’s outstanding stewardship in channeling more than 90% of all funds raised directly to fund rheumatology training and career development research grants. Another goal of this campaign, established from the outset, was to enhance the fundraising potential of the organization. This goal has also been realized, and the REF now has an experienced and effective development staff in place. Thus, as we look forward to a new fundraising campaign, there is the strong sense in the organization that, at the same time we set the next lofty goal, we are now also engaged in “business as usual,” because this is what we do, and we do it well.

Those of you who attended the recent ACR/ARHP Annual Scientific Meeting in Chicago may have seen the first announcement of our new $60-million campaign, Journey to Cure. This campaign moves the REF forward from our previous fundraising successes and encompasses funding for the REF’s two mission priorities—rheumatology training and career development, and disease-targeted research. Journey to Cure serves as a rallying point to expand these mission priorities on a scale never before achieved.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College Tagged With: AC&R, ACR Research and Education Foundation, NIH, REF News, Research, rheumatologyIssue: December 2011

You Might Also Like:
  • REF: Looking at Recent Achievements and FInding Inspiration for the Future
  • Without You, ACR REF Wouldn’t Be Here
  • ACR REF Launches ‘Within Our Reach’
  • Rethink Rheumatoid Arthritis Research

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.